Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of “Hold” by Analysts

Tempus AI, Inc. (NASDAQ:TEM) has been assigned an average recommendation of “Hold” from the fifteen ratings firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and nine have issued a buy rating on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $68.6429.

TEM has been the topic of a number of recent analyst reports. Stifel Nicolaus set a $60.00 price objective on Tempus AI in a research report on Wednesday, February 25th. Needham & Company LLC reissued a “buy” rating and set a $75.00 price objective on shares of Tempus AI in a research note on Monday, June 1st. Mizuho initiated coverage on Tempus AI in a research note on Thursday, February 19th. They set an “outperform” rating and a $100.00 price objective for the company. BTIG Research reissued a “buy” rating and set a $80.00 price objective on shares of Tempus AI in a research note on Monday, June 1st. Finally, JPMorgan Chase & Co. dropped their price objective on Tempus AI from $80.00 to $60.00 and set a “neutral” rating for the company in a research note on Wednesday, February 25th.

Insider Activity at Tempus AI

In related news, EVP Andrew Polovin sold 8,703 shares of Tempus AI stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $44.07, for a total transaction of $383,541.21. Following the completion of the sale, the executive vice president owned 128,215 shares of the company’s stock, valued at approximately $5,650,435.05. This trade represents a 6.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Eric P. Lefkofsky sold 166,250 shares of Tempus AI stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $46.70, for a total value of $7,763,875.00. Following the sale, the chief executive officer directly owned 8,808,533 shares of the company’s stock, valued at $411,358,491.10. This represents a 1.85% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 558,557 shares of company stock valued at $26,611,939 in the last ninety days. 24.26% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently added to or reduced their stakes in the company. Victory Capital Management Inc. raised its position in Tempus AI by 1.5% during the third quarter. Victory Capital Management Inc. now owns 11,078 shares of the company’s stock valued at $894,000 after purchasing an additional 162 shares in the last quarter. US Bancorp DE raised its position in Tempus AI by 6.6% during the third quarter. US Bancorp DE now owns 2,848 shares of the company’s stock valued at $230,000 after purchasing an additional 176 shares in the last quarter. Legacy Bridge LLC raised its position in Tempus AI by 1.6% during the fourth quarter. Legacy Bridge LLC now owns 12,418 shares of the company’s stock valued at $733,000 after purchasing an additional 193 shares in the last quarter. Truist Financial Corp raised its position in Tempus AI by 5.8% during the fourth quarter. Truist Financial Corp now owns 3,532 shares of the company’s stock valued at $209,000 after purchasing an additional 194 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its position in Tempus AI by 3.5% during the fourth quarter. Farther Finance Advisors LLC now owns 6,390 shares of the company’s stock valued at $377,000 after purchasing an additional 219 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Trading Up 4.7%

NASDAQ:TEM opened at $48.59 on Tuesday. The company has a market cap of $8.73 billion, a P/E ratio of -28.25 and a beta of 3.64. The stock’s fifty day moving average price is $48.95 and its two-hundred day moving average price is $57.29. Tempus AI has a 1 year low of $41.73 and a 1 year high of $104.32. The company has a debt-to-equity ratio of 2.96, a current ratio of 3.31 and a quick ratio of 3.15.

Tempus AI (NASDAQ:TEM) last posted its earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.08. The firm had revenue of $348.12 million for the quarter, compared to the consensus estimate of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The business’s quarterly revenue was up 36.1% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.24) earnings per share. As a group, analysts expect that Tempus AI will post -1.35 EPS for the current year.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.